Literature DB >> 1639438

Possible association of the extended MHC haplotype B44-SC30-DR4 with autism.

R P Warren1, V K Singh, P Cole, J D Odell, C B Pingree, W L Warren, C W DeWitt, M McCullough.   

Abstract

We previously reported that the complement C4B null allele appears to be associated with infantile autism. Since the C4B null allele is known to be part of the extended or ancestral haplotype [B44-SC30-DR4], we investigated the incidence of [B44-SC30-DR4] in 21 autistic children and their parents. This extended haplotype was increased by almost six-fold in the autistic subjects as compared with healthy controls. Moreover, the total number of extended haplotypes expressed on chromosomes of autistic subjects was significantly increased as compared with those expressed on chromosomes of healthy subjects. We conclude that a gene related to, or included in, the extended major histocompatibility complex may be associated with autism.

Entities:  

Mesh:

Year:  1992        PMID: 1639438     DOI: 10.1007/bf00215048

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

1.  A molecular basis for MHC class II--associated autoimmunity.

Authors:  J A Todd; H Acha-Orbea; J I Bell; N Chao; Z Fronek; C O Jacob; M McDermott; A A Sinha; L Timmerman; L Steinman
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

2.  Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child.

Authors:  R D Todd; R D Ciaranello
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination.

Authors:  E G Stubbs
Journal:  J Autism Child Schizophr       Date:  1976-09

4.  Increased frequency of the null allele at the complement C4b locus in autism.

Authors:  R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; E White
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

5.  Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.

Authors:  R P Warren; L J Yonk; R A Burger; P Cole; J D Odell; W L Warren; E White; V K Singh
Journal:  Immunol Invest       Date:  1990-06       Impact factor: 3.657

6.  Complement factor C4 in schizophrenia.

Authors:  C Rudduck; L Beckman; G Franzén; L Jacobsson; L Lindström
Journal:  Hum Hered       Date:  1985       Impact factor: 0.444

7.  Abnormal immune response to brain tissue antigen in the syndrome of autism.

Authors:  A Weizman; R Weizman; G A Szekely; H Wijsenbeek; E Livni
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

8.  Depressed lymphocyte responsiveness in autistic children.

Authors:  E G Stubbs; M L Crawford
Journal:  J Autism Child Schizophr       Date:  1977-03

Review 9.  Complotypes and extended haplotypes in laboratory medicine.

Authors:  C A Alper; Z L Awdeh; E J Yunis
Journal:  Complement Inflamm       Date:  1989

10.  Immune abnormalities in patients with autism.

Authors:  R P Warren; N C Margaretten; N C Pace; A Foster
Journal:  J Autism Dev Disord       Date:  1986-06
View more
  18 in total

1.  Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

Authors:  G DelGiudice-Asch; L Simon; J Schmeidler; C Cunningham-Rundles; E Hollander
Journal:  J Autism Dev Disord       Date:  1999-04

2.  Exclusion of linkage to the HLA region in ninety multiplex sibships with autism.

Authors:  T Rogers; L Kalaydjieva; J Hallmayer; P B Petersen; P Nicholas; C Pingree; W M McMahon; D Spiker; L Lotspeich; H Kraemer; P McCague; S Dimiceli; N Nouri; T Peachy; J Yang; D Hinds; N Risch; R M Myers
Journal:  J Autism Dev Disord       Date:  1999-06

3.  Immunological treatments for autism.

Authors:  S Gupta
Journal:  J Autism Dev Disord       Date:  2000-10

Review 4.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

5.  Macrophage migration inhibitory factor and autism spectrum disorders.

Authors:  Elena L Grigorenko; Summer S Han; Carolyn M Yrigollen; Lin Leng; Yuka Mizue; George M Anderson; Erik J Mulder; Annelies de Bildt; Ruud B Minderaa; Fred R Volkmar; Joseph T Chang; Richard Bucala
Journal:  Pediatrics       Date:  2008-08       Impact factor: 7.124

6.  Brief report: immunoglobulin A deficiency in a subset of autistic subjects.

Authors:  R P Warren; J D Odell; W L Warren; R A Burger; A Maciulis; W W Daniels; A R Torres
Journal:  J Autism Dev Disord       Date:  1997-04

7.  Altered T cell responses in children with autism.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2010-09-15       Impact factor: 7.217

Review 8.  The major histocompatibility complex and autism spectrum disorder.

Authors:  Leigh A Needleman; A Kimberley McAllister
Journal:  Dev Neurobiol       Date:  2012-08-23       Impact factor: 3.964

9.  Pathogenesis of autism: a patchwork of genetic causes.

Authors:  Elena L Grigorenko
Journal:  Future Neurol       Date:  2009

10.  Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.

Authors:  Aristo Vojdani; Mohsen Bazargan; Elroy Vojdani; John Samadi; Alen A Nourian; Navid Eghbalieh; Edwin L Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.